Arlington Partners LLC Gsk PLC Transaction History

Arlington Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$40.23 - $47.74 $20,919 - $24,824	-520 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$38.88 - $45.31 $20,217 - $23,561	520 New	520 $23,000
Q2 2020 Jul 13, 2020	SELL	$37.87 - $43.58 $4,658 - $5,360	-123 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$32.47 - $48.83 $6,558 - $9,863	-202 Reduced 62.15%	123 $5,000
Q4 2018 Jan 10, 2019	BUY	$37.8 - $42.69 $12,284 - $13,874	325 New	325 $12,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.5B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.